Welcome to www.pliva.com

New appointments in PLIVA

New appointments in PLIVA

Zagreb, 11th July 2014 - PLIVA CROATIA Ltd. has announced today that Tihomir Orešković, President of its Management Board, has been promoted to a position of CFO Teva Europe, effective 1 September 2014, when he will also start a transition process to his new role. He will also continue to perform his responsibilities as President of the Management Board and work with his teams in Croatia and South East Europe until the end of the year to ensure business continuity.

PLIVA CROATIA Ltd. has announced today that Tihomir Orešković, President of its Management Board, has been promoted to a position of CFO Teva Europe, effective 1 September 2014, when he will also start a transition process to his new role. He will also continue to perform his responsibilities as President of the Management Board and work with his teams in Croatia and South East Europe until the end of the year to ensure business continuity.

Mr. Orešković was appointed as President of PLIVA's Management Board on 1 July 2012. PLIVA is not only the largest pharmaceutical company in Croatia, but also the company that has become one of the biggest investors, particularly in the segments of high-tech production facilities and R&D capacities, and one of the country's leading exporters in the past two years. In the same period, PLIVA has recruited a number of young experts and it has been recognised as one of the most attractive employers thanks to its outstanding HR management practices. 

Mr. Orešković was born in Zagreb in 1966. In 1989 he graduated in chemistry from McMaster University, in Canada, where he also finished his MBA studies (areas of concentration: finance and information systems) in 1991. In 1992, Mr. Orešković started his professional career in the pharmaceutical industry. After joining Teva in 2005, he worked as CFO Teva Canada, and was appointed as CFO for Eastern Europe in 2009. In 2010, he was appointed as CFO for EMIA (Eastern Europe, Mediterranean, Israel and Africa).

Commenting on these changes, Mr. Orešković said: "I have been truly honoured to be part of this great organisation. PLIVA has positioned itself for long-term success in each and every segment of its business operations – production, research and development, and as finance and IT excellence centre and commercial leader. The character of any organisation is defined by its people and I am really proud to be a part of PLIVA. A new position however, just like any other change, gives us an opportunity to meet new people, ideas, cultures and challenges, and all of this is truly enriching.”

Congratulating Mr. Orešković on his appointment, Hubert Puech d’Alissac, President of the Supervisory Board of PLIVA CROATIA, said: “Teva’s greatest assets are definitely its employees, and their wealth of diversity, exceptional expertise and commitment will ensure this organisation’s further development. The knowledge and expertise of our colleagues from Croatia and other South East European countries guarantee that we shall continue to achieve our ambitious plans as one of the largest pharmaceutical companies in this region in the best interest of our patients, as well as of the health care systems and our wider environment."

 

© 2017 PLIVA HRVATSKA d.o.o. / All rights reserved. / Legal information / Impressum